6.
Lu S, Bao M, Miao S, Zhang X, Jia Q, Jing S
. Prevalence of hypertension, diabetes, and dyslipidemia, and their additive effects on myocardial infarction and stroke: a cross-sectional study in Nanjing, China. Ann Transl Med. 2019; 7(18):436.
PMC: 6803213.
DOI: 10.21037/atm.2019.09.04.
View
7.
Wang L, Li X, Wang Z, Bancks M, Carnethon M, Greenland P
. Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018. JAMA. 2021; .
PMC: 8233946.
DOI: 10.1001/jama.2021.9883.
View
8.
Neter J, Stam B, Kok F, Grobbee D, Geleijnse J
. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003; 42(5):878-84.
DOI: 10.1161/01.HYP.0000094221.86888.AE.
View
9.
Li S, Schwartz J, Shimbo D, Muntner P, Shikany J, Booth 3rd J
. Estimated Prevalence of Masked Asleep Hypertension in US Adults. JAMA Cardiol. 2020; 6(5):568-573.
PMC: 7593881.
DOI: 10.1001/jamacardio.2020.5212.
View
10.
Deere B, Ferdinand K
. Hypertension and race/ethnicity. Curr Opin Cardiol. 2020; 35(4):342-350.
DOI: 10.1097/HCO.0000000000000742.
View
11.
Toprak A, Wang H, Chen W, Paul T, Ruan L, Srinivasan S
. Prehypertension and black-white contrasts in cardiovascular risk in young adults: Bogalusa Heart Study. J Hypertens. 2009; 27(2):243-50.
DOI: 10.1097/hjh.0b013e32831aeee3.
View
12.
Li Y, Xia P, Geng T, Tu Z, Zhang Y, Yu H
. Trends in Self-Reported Adherence to Healthy Lifestyle Behaviors Among US Adults, 1999 to March 2020. JAMA Netw Open. 2023; 6(7):e2323584.
PMC: 10349344.
DOI: 10.1001/jamanetworkopen.2023.23584.
View
13.
Booth 3rd J, Li J, Zhang L, Chen L, Muntner P, Egan B
. Trends in Prehypertension and Hypertension Risk Factors in US Adults: 1999-2012. Hypertension. 2017; 70(2):275-284.
PMC: 5594566.
DOI: 10.1161/HYPERTENSIONAHA.116.09004.
View
14.
Fan Z, Yang C, Zhang J, Huang Y, Yang Y, Zeng P
. Trends and influence factors in the prevalence, awareness, treatment, and control of hypertension among US adults from 1999 to 2018. PLoS One. 2023; 18(9):e0292159.
PMC: 10538741.
DOI: 10.1371/journal.pone.0292159.
View
15.
Borghi C, Domienik-Karlowicz J, Tykarski A, Widecka K, Filipiak K, Jaguszewski M
. Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk: 2021 update. Cardiol J. 2021; 28(1):1-14.
PMC: 8105060.
DOI: 10.5603/CJ.a2021.0001.
View
16.
King J, Pinheiro L, Ringel J, Bress A, Shimbo D, Muntner P
. Multiple Social Vulnerabilities to Health Disparities and Hypertension and Death in the REGARDS Study. Hypertension. 2021; 79(1):196-206.
PMC: 8665033.
DOI: 10.1161/HYPERTENSIONAHA.120.15196.
View
17.
Du Y, Liu B, Sun Y, Snetselaar L, Wallace R, Bao W
. Trends in Adherence to the Physical Activity Guidelines for Americans for Aerobic Activity and Time Spent on Sedentary Behavior Among US Adults, 2007 to 2016. JAMA Netw Open. 2019; 2(7):e197597.
PMC: 6661709.
DOI: 10.1001/jamanetworkopen.2019.7597.
View
18.
Fang M, Wang D, Coresh J, Selvin E
. Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018. N Engl J Med. 2021; 384(23):2219-2228.
PMC: 8385648.
DOI: 10.1056/NEJMsa2032271.
View
19.
Cheng S, Xanthakis V, Sullivan L, Vasan R
. Blood pressure tracking over the adult life course: patterns and correlates in the Framingham heart study. Hypertension. 2012; 60(6):1393-9.
PMC: 3499677.
DOI: 10.1161/HYPERTENSIONAHA.112.201780.
View
20.
Vasan R, Beiser A, Seshadri S, Larson M, Kannel W, DAgostino R
. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA. 2002; 287(8):1003-10.
DOI: 10.1001/jama.287.8.1003.
View